Pharmaceutical Patent Laws: A Prescription for Success in Challenging Times

October 10, 2008

BNA, a leading provider of expert information and analysis, is holding a one-day, information-packed conference, titled “Pharmaceutical Patent Laws: A prescription for Success in Challenging Times.” Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will be on a panel discussion of Non-Patent Marketing Exclusivity with Brian McCormick (Hogan & Hartson), Stephen Albainy-Jenei (Frost Brown Todd LLC; Patent Baristas Blog), and Shashank Upadhye (Apotex).

Billed as a conference to “get a prescription for success as legislative, judicial, administrative, and ‘marketplace’ developments continue to advance at breakneck speed,” the conference is intended to help participants:

  • Get maximum value from your patents;
  • Learn winning litigation tactics from leading practitioners;
  • Avoid antitrust consequences when settling cases; and
  • Look for trends – where does case law go from here?

The conference will be held at the Ritz-Carlton, Pentagon City, 1250 South Hayes Street, Arlington, VA, on November 12, 2008. A copy of the conference brochure is available here. Additional conference information is available here.

Special FDA Law Blog Discount – BNA is offering FDA Law Blog readers a 40% discount off of the registration fee. Further, if you sign up two people at the discounted rate, the third person is free. To register for the conference, go to the BNA website and enter the following code – [CONF40NE]. FDA Law Blog is a conference media sponsor.

Categories: Hatch-Waxman